Vast Majority of American Ebola Patients Are Recovering


Selenium deficiency makes ebola more likely to be lethal.  Eat a Brazil nut a day, says Scott Tips.

Nurse to Challenge Fear-Based Policy

How are we measuring threats of disease against the rights of individuals? It appears our rights are gone when the threats appear as minor as possible, while an incompetent government and fear mongering media led by big pharma mislead and conquer.

My guess is that Hickox was released because they feared facing a court challenge that might set a precedent conflicting with the existing Supreme Court rulings about forced vaccinations and forced sterilization. If so, it was “too little, too late,” as Kaci Hickox is still going ahead with a lawsuit. As reported by Reuters7 on October 28:

“Norman Siegel, a civil rights lawyer, said Kaci Hickox’s isolation upon her return from West Africa raised ‘serious constitutional and civil liberties issues,’ given that she shows no Ebola symptoms and has not tested positive for the disease.

‘We’re not going to dispute that the government has, under certain circumstances, the right to issue a quarantine,’ said Siegel… ‘The policy is overly broad when applied to her.’

The lawsuit would be the first to challenge the 21-day mandatory quarantine imposed by New Jersey for anyone arriving with a high risk of having contracted Ebola from Sierra Leone, Liberia and Guinea… The case could also affect similar policies announced by other states including New York and Illinois.

The lawsuit will argue that Hickox’s constitutional right to due process was violated when she was forced into isolation… State officials implemented a blanket policy without identifying a rational basis for confining asymptomatic individuals like Hickox, he said. ‘The case law makes clear that the policy should be driven by medical fact, not fear,’ he said.”

Vast Majority of American Ebola Patients Have Recovered

Vaccine makers are shielded against lawsuits if a vaccine is either added to the vaccination schedule or classified as a pandemic vaccine. But there may not be enough Ebola victims to justify pandemic classification in the US.

As reported by Forbes8 on October 21, 80 percent of then-diagnosed Ebola patients in the US have in fact survived—and most of those without a vaccine or other Ebola-specific medication. So far, only one American patient, Thomas Duncan, who was the first person diagnosed with Ebola in the US, has died from the disease.

Amber Vinson, a nurse who initially tested positive for the virus, has since been confirmed virus-free and has been moved out of isolation.9 Another unnamed American Ebola patient who had been working with WHO in Sierra Leone was discharged from Emory University Hospital on September 19—10 days after being admitted and treated for Ebola.

Missionary Nancy Writebol, who contracted the disease while doing aid work in Liberia, was discharged Emory University Hospital on August 19 after being treated for two weeks. Dr. Kent Brantly, another aid worker, was also discharged after nearly three weeks of treatment.

Brantly and Writebol both received the experimental and as-of-yet unapproved drug Zmapp. Maternity ward nurse Debbie Sacra, diagnosed with Ebola on September 3, received a blood transfusion from Dr. Brantly, and was also found to be virus-free on September 25.

On October 23, Dr. Spencer Craig, who had treated Ebola patients in Guinea, tested positive for the virus in New York City, and is currently in isolation at Bellevue Hospital Center.10 He’s described as being “in good shape.” The next day, October 24, Dallas nurse Nina Pham who’d been diagnosed with Ebola on October 12, was announced virus-free, according to the National Institutes of Health (NIH). Cameraman Ashoka Mukpo, who contracted the disease while on assignment in West Africa, was also released from the hospital on October 22 after spending just over two weeks in isolation.11 He too received a blood transfusion from Ebola survivor Dr. Brantly.

Selenium Deficiency Could Potentially Play an Important Role in Ebola Lethality

Here’s yet another factor that could play an important role in the Ebola outbreak: selenium deficiency. The documented relationship between low selenium status and impaired immunity in relation to Ebola goes back to 1995. Intriguing evidence suggests that the lethal hemorrhaging associated with the Ebola virus may be influenced by a lack of selenium…

According to Dr. Gary Gordan, adults need at least 400 micrograms (mcg) of selenium per day, but if the virus is making seleno-proteins—which Ebola is thought to do—you may need several times that amount. The documentation I’m referring to was published in the Journal of Orthomolecular Medicine in 1995,15 and reads in part:

The expression of this hypothetical protein could impose an unprecedented selenium demand upon the host, potentially leading to severe lipid peroxidation and cell membrane destruction. This could also contribute to the characteristic hemorrhaging caused by intravascular blood clotting, due to the thrombotic effect of selenium (Se) deficiency. The possibility that this gene might contribute to the extreme pathogenicity of the Zaire strain of Ebola virus by this mechanism is also consistent with the observation that this potential selenoprotein gene is not present in the Ebola Reston strain, which was not pathogenic in humans…

It is very well documented that selenium plays a significant role in the regulation of blood clotting via its effects on the thromboxane/prostacyclin ratio. Selenium has an anti-clotting effect, whereas selenium deficiency has a pro-clotting or thrombotic effect. Selenium deficiency has been associated with thrombosis and even hemorrhaging, which has been documented in a number of animals with severe selenium deficiency… but is almost never seen in humans, probably because such an extreme selenium deficiency is rarely attained due to the diversity of human diets.

Thus, the possibility that a rapid depletion of selenium due to the formation of viral selenoproteins could be a factor contributing to the severity of the hemorrhagic symptoms is mechanistically very feasible. Our analysis suggests thatsevere Ebola infections could produce an artificial and extreme Se depletion, resulting in extensive cellular damage due to lipid peroxidation, combined with enhanced thrombosis.

This could also contribute to the associated immune deficiency that has been observed in Ebola infections.

To our knowledge, indicators of Se status and lipid peroxidation have never been examined in Ebola patients. However, selenium has apparently been used with great success by the Chinese in the palliative treatment of an infectious hemorrhagic fever. Although this did not involve Ebola virus, there are a number of different hemorrhagic fever viruses, and they may share common mechanisms. This example provides yet another reason to expect that pharmacological doses of selenium may also have some benefit in Ebola infections.” [Emphasis mine]


TAP – According to Scott Tips,  President of The National Health Federation, the best way to fix a selenium deficiency is to eat just one Brazil nut every day.   Ebola (and other infections) sorted.



Leave a Reply

You must be logged in to post a comment.